Healthcare-acquired infections (HAIs) kill tens of thousands of people each year 15 and add significantly to healthcare costs. Multidrug resistant and epidemic strains are a 16 large proportion of HAI agents, and multidrug resistant strains of Klebsiella pneumoniae, 17 a leading HAI agent, have become an urgent public health crisis. In the healthcare 18 environment, patient colonization of K. pneumoniae precedes infection, and transmission 19 via colonization leads to outbreaks. Periodic patient screening for K. pneumoniae 20 colonization has cost-effective and life-saving potential. In this study, we describe the 21 design and validation of KlebSeq, a highly informative screening tool that detects 22
INTRODUCTION 32
Klebsiella pneumoniae has been a leading healthcare-acquired infection (HAI) agent for 33 decades (1, 2). Emergence of multidrug-resistant K. pneumoniae, especially expanded-34 spectrum β-lactamase (ESBL) producers and carbapenemase producers, has elevated the 35 morbidity and mortality rates and healthcare costs associated with K. pneumoniae to 36 factor for infection (22) (23) (24) , and carriers of CPE are at high risk for invasive disease (25) . 48
Rates of CPE and ESBL-producing K. pneumoniae colonization are rising in patient and 49 healthcare worker populations, increasing the size of the reservoir, and increasing 50 chances of transmission (26, 27) . Asymptomatic transmission of multidrug resistant 51 strains is rapid (16, 28) , and transmission events that lead to outbreaks often go 52 undetected (29, 30) . Early detection of K. pneumoniae colonization of healthcare patients, 53 especially multidrug resistant K. pneumoniae or epidemic strain type colonization, is now 54 considered critical to infection control (24, (30) (31) (32) (33) . 55
Infection control programs that include detection and isolation of carriers have 56 repeatedly been successful in markedly decreasing multidrug resistant or epidemic strain 57 infections (31, (34) (35) (36) (37) , but this practice is uncommon. Many of these programs use 58
culture-based methods such as antibiotic-containing broth enrichment or selective media 59
METHODS 83
Samples. Isolates for target identification and assay validation, along with DNA 84 extracted from clinical specimens were acquired through collaborations with a large 85 hospital reference laboratory that receives specimens from ten system-wide medical 86 centers in Arizona, and from a high volume private reference laboratory that receives 87 specimens from regional inpatient, long-term care, and outpatient facilities. Clinical 88 specimen types included various respiratory specimens (nasal, ear, and throat swabs, 89 sputa, tracheal aspirates, and bronchial alveolar lavages), urine, and wound swabs or 90 tissue. DNA was extracted from isolates by Qiagen DNeasy Blood and Tissue Kit with 91 additional lytic enzymes when appropriate. DNA was extracted from clinical specimens 92 by NucliSENS easyMAG (bioMerieux, Durham, NC) . DNA from healthy donor fecal 93 samples was acquired from a family microbiome study. Samples had been collected from 94 members of seven families over multiple timepoints. DNA was extracted following the 95 Earth Microbiome Project protocol (40) . 96
Assay target identification and assay design. Figure 1 illustrates the 97 methodologies and resources utilized, also described below, to amass a target library and 98 develop several types of amplicon sequencing assays. 99
Whole genome sequencing, SNP detection, and phylogenetic analysis. In-100 house genome libraries were prepared from 130 Klebsiella isolates with a 500 base pair 101 insert size using KAPA Library Preparation Kit with Standard PCR Library 102 Amplification (Kapa Biosystems, Wilmington, MA) and sequenced on Illumina's GAIIx 103 or MiSeq. Public genome sequence data from 277 K. pneumoniae, 18 K. 104 quasipneumoniae, and 13 K. variicola isolates were downloaded from the SRA database 105 quasipneumoniae, and 11 K. variicola from the Assembly database 107 (http://www.ncbi.nlm.nih.gov/assembly), and all passed filters for high quality. The 108 publicly available bioinformatic tool NASP (41), developed for microbial genome 109 analysis, was used to detect single nucleotide polymorphisms (SNPs) among the 110 genomes. In brief, reads were aligned to a reference genome, either one from 111 concatenated scgMLST alleles (10) or MGH 78578 (Genbank accession no. CP000647) 112
using Novoalign (Novocraft.com) and SNPs were called with GATK (42). Data filtered 113 out included SNP loci with less than 10X coverage or with less than 90% consensus in 114 any one sample, regions duplicated in the reference genome as identified by Nucmer, and 115 SNP loci that were not present in all genomes in the dataset. In NASP, results were 116 output in a SNP matrix from a core genome common to all isolates in the analysis. 117
Phylogenetic trees were generated from the NASP SNP matrices using MEGA 6.0 (43) 118 and subsequently plotted by means of ITOL v2 or v3 (44). 119
Genomic target identification. To find whole gene targets for assay design, 120 select genomes were assembled with UGAP (https://github.com/jasonsahl/UGAP), which 121 uses the SPAdes genome assembler (45). Assemblies were then run through LS-BSR 122 (46), which generates a list of ORFs that have high identity among target species 123 genomes and that have low identity or are not present in non-target genomes. Alleles of 124 the candidate target ORFs were collected by BLAST, including alleles from non-target 125 genomes if present. Lastly, alleles of candidate ORFs were aligned for assay design. Two 126
ORFs (M1 and M2) were collected for two K. pneumoniae-specific assays. Canonical 127 chloramphenicol, and fosfomycin resistance genes, and the recently discovered plasmid-140 mediated colistin resistance gene mcr-1. Virulence targets include several siderophore 141 systems, for which multiple genes from each were used as assay targets, the regulator of 142 mucoid phenotype (an indicator of a hypervirulence), and wzi gene for capsule typing, for 143 which we used the published assay (48), and two genes highly associated with invasive 144 infection pK2044_00025 and pK2044_00325 (47). For genes that consist of highly 145 diverse alleles, for example bla CTX-M , qnrB, or dfrA, phylogenetic trees based on 146 nucleotide sequences were generated in order to group similar alleles for assay design. 147
Assay design and validation. Gene-based target alleles were aligned in SeqMan 148 (DNAStar, Madison, WI) to identify conserved regions for primer design, and assays 149 were designed with guidance from RealTimeDesign™ (Biosearch Technologies, 150 Palo Alto, CA), which designs assays to capture alleles in an alignment rather than to 152 individual sequences. SNP assay primers were designed using RealTimeDesign™, and 153 primer sequences were checked for conservation in the NASP SNP matrix. Lastly, assays 154 were run through BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi, to check for cross-155 reactivity to other relevant targets or species, including human. Universal tails were 156 added to each primer sequence for library preparation, as described in Amplicon library 157 preparation below. The assays and their primer sequence are listed in Table S1 . 158
Individual assays were screened across positive controls when accessible, and 159 screened across several isolate gDNAs to increase confidence in robustness, especially 160 when known positive controls were not available. Additionally, multiplex PCR was 161 validated by initial gene-specific PCR (described below) followed by PCR product 162 dilution, then screening of individual assays by Sybr green-based qPCR. For this, 10 µL 163 reactions of 1X Platinum SYBR Green qPCR SuperMix (ThermoFisher Scientific, 164
Waltham, MA), 200 nM forward and reverse primers of one assay, and 1 µL diluted 165 multiplex PCR product were run at 95°C initial denaturation for 4 min, then 40 cycles of 166 95°C for 15 s and 60°C for 1 min. Lastly, several panels of known isolate DNAs were 167 screened with the amplicon sequencing method to test for sensitivity and specificity of 168 the species and strain identification assays. AMR and virulence gene assays were 169 validated by comparing amplicon sequencing results with whole genome sequence data. 170
Amplicon library preparation and sequencing. Amplicon library preparation 171 using universal tails was described in detail previously (49 Phylogenetic analysis and canSNP identification. Using the Klebsiella strict core 209 genome MLST (scgMLST) (10) assembly as a reference, SNPs among a diverse set of 210 genomes from K. pneumoniae and genomes from the newly defined K. quasipneumoniae 211 (22 from the public databases and one from in-house isolates) and K. variicola (24 from 212 the public databases and five from in-house isolates) were identified with NASP. A 213 canonical SNP that differentiates K. quasipneumoniae and one that differentiates K. 214 variicola from K. pneumoniae were selected for assay development. 215
Using the reference genome MGH 78578 and 548 diverse K. pneumoniae 216 genomes, NASP generated a SNP matrix from which canonical SNPs for each of the 217 major clonal groups were selected for assay development. Clonal groups and locations of 218 canSNPs identifying 35 clonal groups and sequence types in the context of the K. 219 pneumoniae species are illustrated in Figure 2 . Redundancy was intentionally included in 220 the assays expected to be positive for the most epidemic strains of K. pneumoniae such as 221 ST14, ST20, and strains in CG258 in order to increase confidence in positive results. 222
KlebSeq validation. For validation of the species and clonal group identification 223 assays, genomic DNA from 73 K. pneumoniae isolates that had also been whole genome 224 sequenced (4 of which were later identified as K. quasipneumoniae and K. variicola, see 225 below), 22 K. oxytoca isolates, and 157 other enteric, opportunistic-pathogen isolates, 226 two assays Kp-M1 and Kp-M2, which target two different K. pneumoniae species-232 specific genes (M1 and M2), 100% sensitivity is achieved. One isolate previously 233 identified as K. pneumoniae typed as K. quasipneumoniae and two as K. variicola. These 234 isolates' whole genomes were added to the phylogenetic analysis of these three species 235 that was previously run to find the species-specific canSNPs (see Methods). The K. 236 quasipneumoniae and K. variicola genomes identified by our assay clustered with their 237 respective species in the phylogeny (Fig. 3) . Clinical methods do not currently distinguish 238 among all three of these species, so assay sensitivity and specificity were not calculated 239 for K. quasipneumoniae and K. variicola. 240 Table 2 shows results of the K. pneumoniae clonal group identification and 241 capsule typing assays. Each isolate's strain type was correctly captured by the appropriate 242 Partial sequencing of the wzi gene for capsule typing gave surprisingly clear results, 244
given that approximately 75 bp of the informative region is missing in our sequence 245 output, as it was based on a previously published assay (48). The amplicon size of the wzi 246
PCR is approximately 580 bp, which is too long to cover with the Illumina version 2 247 sequencing chemistry. However, our data show the promise of full capsule typing by wzi 248 sequence with longer read chemistry (i.e. Illumina version 3 chemistry, which provides 249 2x300 bp reads). Results from screening non-target organisms showed that several of the 250 K. pneumoniae clonal group assays amplified DNA from other organisms, as was 251 expected, however all SNP states that define a particular clonal group are specific to that 252 clonal group. As such, sequence analysis by ASAP reported when a clonal group was 253 present only if the defining canSNP state was present, and reported nothing if it was not. 254 AMR gene detection by amplicon sequencing was validated by comparing ASAP 255 results with AMR gene screening of whole genome sequence with SRST2 (54). Results 256 showed good correlation with few discrepancies, which were almost all negative by 257 amplicon sequencing while positive by SRST2. This may have been due to PCR primer 258 discrepancy or inefficiency or failure in amplicon library preparation. Only six samples 259 account for a majority of the negatives, which points to the latter alternative. Virulence 260 gene detection was validated by comparing ASAP results from whole genome sequence 261 data with those from amplicon sequence data. Results showed almost perfect 262
concordance. In addition, by targeting genes that are part of the same virulence factors 263 (i.e. siderophore systems), sensitivity and confidence in results was increased. Important clonal groups of Klebsiella were detected in multiple specimens. In the 278 18 urine samples positive for K. pneumoniae, clonal identifications included CG34, 279 ST20, CG45, CG392 (which includes the NDM-producer ST147 (55), though these 280 samples were negative for bla NDM , n=2), ST133, and CG111. In wounds, one strain 281 identification, CG29, was made from the three K. pneumoniae-positive samples. From 282 respiratory specimens, groups CG37 (n=2), ST134 (n=1), ST258 (n=2), CG36 (n=3), and 283 innerST14 (n=1) were identified. Interestingly, several clonal groups were identified in 284 the healthy donor fecal specimens as well. Out of the eight K. pneumoniae-positive 285 samples, groups included ST20 (an alignment of which is shown in Figure 4 ), CG37, and 286 CG76, which are all members of multidrug-resistant outbreak strain types (11, 12, 15) , 287 along with ST133 and ST380. ST380 is associated with a K2 capsule type and 288 hypervirulence, and causes pyogenic liver abscesses in healthy people, especially of 289
Asian ethnicity (56). Many Asians are colonized with hypervirulent, K1 or K2 capsule 290 strain types; however the level of risk of subsequent liver infection is unknown (56). For 291 this sample, no wzi gene sequence was obtained, thus the capsule type is unknown. A 292 majority of the K. pneumoniae in our samples did not fall into the major clonal groups 293 targeted by KlebSeq. Likely these strains all belong to lesser-known clonal groups, as 294 more studies are showing that many K. pneumoniae infections are caused by non-295 epidemic, sporadic strains (57, 58) . 296
Numerous and variable AMR genes were detected in the specimens, including 297 different variants of the same gene that confer different phenotypes. Using sequence-298 based information, we demonstrate that many of the K. pneumoniae had key mutations in 299 the gyrA gene known to confer resistance to fluoroquinolones. Additionally, several 300 samples contained the aac(6')-Ib gene for aminoglycoside resistance, and some of those 301 contained the minor sequence variant aac(6')-Ib-cr for fluoroquinolone resistance; 302 mixtures of these two genes were also detected. A majority of the infection specimens 303
(non-healthy donor specimens), both positive and negative for K. pneumoniae, were 304 positive for other aminoglycoside resistance genes, as well as tetracycline, TMP-SMX, 305 streptomycin, fosfomycin, and chloramphenicol resistance genes. A few contained 306 plasmid-mediated quinolone resistance genes. Several samples, especially the respiratory 307 specimens, were also positive for KPC and CTX-M groups 1 and 9 genes. Most of the 308 healthy donor specimens were positive for TMP-SMX resistance genes, and many for 309 streptomycin, aminoglycoside, tetracycline, and fosfomycin resistance genes. Some also 310 contained plasmid-mediated quinolone resistance genes. Fortunately, none were found to 311 contain ESBL or carbapenemase genes. No complex specimens in the study were positive 312 for genes encoding the important carbapanemases OXA-48, VIM, or NDM, and none 313 were positive for the plasmid-mediated colistin resistance gene mcr-1. 314
These sets of samples did not appear to contain especially virulent strains of K. 315 pneumoniae. The yersiniabactin siderophore genes were by far the most prevalent of the 316 virulence genes tested, although positive samples made up less than half of the K. 317 pneumoniae-positive samples (46%). No samples were positive for rmpA, regulator of 318 mucoid phenotype gene, including the ST380-containing sample, and few were positive 319 for the salmochelin siderophore genes, which are associated with invasive K. pneumoniae 320 infection (47). One respiratory specimen that contained a ST14 strain was positive for a 321 K2 capsule type by partial wzi sequencing. K2 strains of K. pneumoniae are associated 322 with hypermucoviscosity and hypervirulence, as previously mentioned. However this 323 respiratory sample was not positive for rmpA, and a recent study proposed that the 324 presence of multiple siderophore system genes (linked to K1 or K2 capsule genes) 325 explains hypervirulence rather than capsule type (47). In our data, K. pneumoniae-326 containing samples were positive for multiple siderophores or other virulence-associated 327 genes only 15% of the time. Sequencing of wzi revealed a variety of capsule types, and 328 incidences where the same clonal groups had different wzi genotypes and where they had 329 the same genotype. This character would help identify or rule out a transmission event 330 when patients carrying the same strain are found. 331
On an interesting note, in the healthy donor fecal samples collected from 332 members of the same families over time, out of the eight K. pneumoniae-positive 333 samples, only two came from the same person over time. The characterization assays 334 suggest that the same strain of K. pneumoniae was present at both time points. The fact 335 that there were not more cases of positive results from the same person in multiple rather 336 than single time points is interesting. This could be due to intermittent shedding of K. 337 pneumoniae in feces, intermittent colonization of K. pneumoniae, or heterogeneity in the 338 sample itself, underrepresenting the full microbial community when a small sample is 339 taken. K. pneumoniae-positive samples were found in multiple members of two of the 340 seven families. In one of these families, the positive members carried different strains 341 from one another, and in the other it appears two members shared a CG37 with the same 342 capsule type. The sample set is too small to draw conclusions from the data; however, the 343 data raise interesting questions about community K. pneumoniae carriage. Early detection of K. pneumoniae colonization of healthcare patients, especially 359 multidrug resistant K. pneumoniae, would allow healthcare staff to make more informed 360 patient management decisions. In outbreak situations, rapid identification of 361 transmissions before subsequent infections would allow for proactive measures to curb an 362 outbreak. In non-outbreak situations, identification of particular strains and AMR genes 363 would help to assess the risk of K. pneumoniae carriage to the host patient as well as to 364 other patients, as some strains are more associated with outbreaks, HAI, AMR, and 365 treatment failure than others (7-13, 62). Likewise, identification of virulence genes also 366 informs risk, as particular virulence factors are more associated with pathogenic than 367 colonizing K. pneumoniae (47). Additionally, many K. pneumoniae infections, including 368
HAIs and non-multidrug resistant infections, are caused by non-epidemic, lesser-known 369 strain types (57, 58). Classifying the K. pneumoniae in each patient sample would help 370 an institution decide when and which intervention procedures should be enacted, and also 371 understand more about transmission dynamics and local strain type circulation. 372
The amplicon sequencing assay and analysis pipeline described here has several 373 characteristics that make it ideal as a healthcare screening tool. With a single assay, 374 enough information is garnered about a patient's Klebsiella carriage status to contribute 375 greatly to patient management or to infection control decisions. Indexing samples by 376 means of the universal tail during sample preparation allows characterization of a large 377 number of specimens in one run, minimizing sequencing costs per specimen and allowing 378 for high-throughput screening of hundreds of patient samples simultaneously. KlebSeq 379 uses DNA extracted directly from a specimen so targets from entire populations of a 380 species are analyzed to capture different strains in the same sample, which can be 381 numerous (63, 64). If culture-based methods are used for screening, different strains are 382 missed when one genotype (i.e. colony) is chosen for characterization, and resulting 383 information is limited. Additionally, culture-based methods can miss "silent" multidrug 384 resistant K. pneumoniae that test negative for carbapanemases in vitro (16) (47), and we identify cases where these 404 species were previously misidentified as K. pneumoniae. We highlight several instances 405 where culture methods failed to produce a positive K. pneumoniae result, including one 406 sample that contained the critical ST258 strain. We identified dozens of AMR and 407 virulence genes within individual samples, demonstrating the additional function of 408 profiling for clinically important characteristics, and were able to distinguish minor 409 genotype differences that confer different phenotypes, i.e. the gyrA gene, aac(6')-Ib 410 versus aac(6')-Ib-cr, and the wzi gene. 411
Notably, our data show that several healthy individuals carry clinically important 412 strains of K. pneumoniae as well as many AMR genes and siderophore virulence systems. 413
For our purposes, these healthy donor fecal DNA samples were used to validate the usage 414 of our amplicon sequencing approach on highly complex gut metagenome samples. Much 415 more study is needed to elucidate the implications of healthy host carriage of known 416 pathogenic strains of K. pneumoniae. Furthermore, the fact that we observed carriage of 417 the hypervirulence-associated ST380 strain from a healthy person, and the 418 hypervirulence-associated K2 capsule type in a ST14 strain from a respiratory infection, 419 lends credence to the idea that we need much more information about avirulent K. 420 pneumoniae to be able to draw conclusions about these associations. 421
Overall, the KlebSeq method was able to accurately and consistently identify and 422
characterize Klebsiella from complex specimens. A limitation to our study is that clonal 423 group identification in the complex specimens was not confirmed by either whole 424 metagenomic sequencing or from isolation and whole genome sequencing of the 425 it can't be known which organism carries the genes. However, KlebSeq is designed for 428 screening and surveillance for high-risk situations using a rule-in/rule-out determination 429 of the possibility of transmission events and through identification of high-risk multidrug 430 resistant or epidemic strains of Klebsiella. For these purposes, KlebSeq is ideal. The 431 specimen types used to validate could be considered a limitation, as we did not test rectal 432 swabs, a common specimen type for CPE surveillance, due to unavailability. However, 433 we show KlebSeq works on different swab types and fecal specimens, which addresses 434 the challenges of detection in rectal swabs. Turnaround time from sample collection to 435 result, is dependent only on current technology (not organism culture). We recently ran a 436 proof of concept of a 24-hour sample-to-answer test using different targets (data not 437 shown). This test was done on an Illumina MiSeq using only 60 cycles. Other platforms 438 may allow for this turn around time to be decreased even further 439
Rapid amplicon sequencing with automated analysis and reporting is a promising 440 response to the proposal for constant surveillance for highly transmissible or highly drug 441 resistant pathogens. Our model system, directed at Klebsiella, can easily be adapted for 442 multiple other pathogens and for different purposes such as environmental sampling, 443 community host screening, and, as smaller, more on-demand next-generation systems 444 become available, for diagnostics and individual patient monitoring. For several reasons, 445 amplicon sequencing is an applicable tool for healthcare facility surveillance. As these 446 technologies are adopted, considerable coordination within the healthcare facility is 447 paramount to the success of infection and outbreak prevention, with the integration of 448 isolation and barrier precautions, excellent communication, and good stewardship. 449
Nevertheless, several institutions have shown that the combination of surveillance and 450 systematic response reduces outbreaks and multidrug resistant infections (31, (33) (34) (35) (36) (37) . 451
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